Home Trending Stocks Eloxx Pharmaceuticals, Inc. (ELOX) Stock Trending Higher Following Funding Award from Cystic...

Eloxx Pharmaceuticals, Inc. (ELOX) Stock Trending Higher Following Funding Award from Cystic Fibrosis Foundation

Eloxx Pharmaceuticals, Inc. (ELOX) stock prices were up by 5.67% as of the market closing on May 27th, 2021, bringing the price per share up to USD$1.49 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by 7.38%, bringing it up to USD$1.60.

Acquisition of Zikani Therapeutics

April 1st, 2021 saw the acquisition of Zikani Therapeutics, Inc., a ribosomal modulation company, in an all-stock transaction. ELOX cited the motivation behind the acquisition as wanting to maximize the potential for ELX-02 for CF, which is currently in Phase 2 development. The collaboration also results in the addition of a preclinical stage pipeline in rare diseases and oncology targeting RNA and ribosomal mutations. The company expects to file an Investigational New Drug Application for the first oral drug to treat patients with Recessive Dystrophic and Junctional Epidermolysis Bullosa in 2022.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Development of Phase 2 ELX-02 Program

The company also recently announced the addition of a new study arm to its global Phase 2 clinical program for ELX-02 in regard to the treatment of CF in patients with at least one G542X allele. The Phase 2 clinical program now include a fifth treatment arm to evaluate the safety of ELX-02 in combination with Kalydeco. Kalydeco is an FDA-approved CF transmembrane conductance regulator (CFTR) potentiator. It is used for the treatment of CF in patients with at least one mutation in their CF gene amenable to ivacaftor. The company is forecasting presenting data from the first four treatments in the second half of 2021.

Net Loss Reports

ELOX reported a net loss of USD$8.7 million for the quarter ended March 31st of the fiscal year 2021, representing a net loss of USD$0.22 per share. USD$1.3 million contributed to this number in the form of stock-based compensation. These numbers reflect an improvement from the net loss of USD$13.9 million reported in the same quarter of the year prior, representing a net loss of USD$0.35 per share.

Solid Liquidity Position

The company reported a solid liquidity position as of March 31st, 2021, with records indicating ELOX having USD$18.2 million in cash and cash equivalents. The capital available to the company is planned to be allocated towards funding company operations through to the third quarter of the fiscal year 2021.

Future Outlook for ELOX

Armed with a solid liquidity position and a prospectively lucrative partnership, ELOX is poised to further develop its pipeline to reach commercialization and, therefore, further growth. Current and potential investors are hopeful that the company will be able to leverage the resources at its disposal to facilitate significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam